Register for free to listen to this article
Listen with Speechify
0:00
1:00
Phenomenex Inc.  
 
Phenomenex Inc. has introduced Kinetex, ultra-highperformance LC columns based on the company's new core-shell silica technology.Kinetex meets researchers' need to improve results and increase productivitywithout large capital expenditures. By delivering significant improvements inspeed and separation efficiency over traditional 3- and 5-micron columns,Kinetex enables chromatographers to get performance comparable to sub-2 microncolumns without investing in UHPLC systems. With Kinetex, researchers canachieve UHPLC results on any LC instrument platform, and any chromatographicmethod can now be completed at a fraction of the time previously required,without sacrificing performance. The increased separation efficiencies ofKinetex also significantly reduce solvent usage and maintain long column life.Initially, Kinetex core-shell columns are available in two particle sizes—2.6and 1.7 micron—and three chemistries—C18, PFP and HILIC.   
 
Phenomenex Inc.
www.phenomenex.com
(310) 212-0555

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering of motor neurons lit up with blue, purple, orange, and green coloring showing synapses against a black background.

Improving ALS research with pluripotent stem cell-derived models 

Discover new advancements in modeling amyotrophic lateral sclerosis.

Automating 3D cell selection

Discover precise automated tools for organoid and spheroid handling. 
An illustration of the tumor microenvironment, showing cancer cells, T cells, and nanoparticles interacting within a complex biological system

A closer look at the tumor microenvironment 

New technologies are allowing researchers to delve deeper into the complex tumor landscape.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue